The Longview: Fireside Chat with Biodexa CEO Stephen Stamp
Today's interview with Stephen Stamp, CEO of Biodexa Pharmaceuticals PLC (NASDAQ:BDRX) is about the Company's lead program, eRapa in Familial...
Today's interview with Stephen Stamp, CEO of Biodexa Pharmaceuticals PLC (NASDAQ:BDRX) is about the Company's lead program, eRapa in Familial...
Company to Highlight Next Stage of PH-762 Clinical Development in Cutaneous Squamous Cell CarcinomaKing of Prussia, Pennsylvania--(Newsfile Corp. - September...
CALGARY, AB AND VANCOUVER, BC / ACCESS Newswire / September 22, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF) (Frankfurt:W1H, WKN:A3EKSZ) ("Onco")...
The strategic collaboration will expand access to global oncology insights for physicians across BrazilNEWARK, N.J., Sept. 22, 2026 /PRNewswire/ -- Medscape,...
Collaboration will integrate Sanguina's AI-enabled patented fingernail analysis technology into My Pediatric Doctor and My Adult Doctor, with future applications...
Rachel Zoe's unique designed jacket features a checked pattern scannable code to drive increase in cancer screenings COLUMBUS, Ga., Sept....
Initiative integrates Aranscia's 2bPrecise and Spesana platforms with leading molecular laboratories to streamline genomic testing across Northside's cancer care networkHOUSTON...
Initiative integrates Aranscia's 2bPrecise and Spesana platforms with leading molecular laboratories to streamline genomic testing across Northside's cancer care networkHOUSTON...
Clinical Milestone Expands Development of Paxalisib Beyond Oncology and Triggers $2 Million Payment to KaziaSYDNEY, Sept. 22, 2026 /PRNewswire/ --...
NORTHAMPTON, MA / ACCESS Newswire / September 22, 2026 / Originally published on DevexLung cancer remains the leading cause of...
Expanded clinical team supports faster access to gastrointestinal and liver care throughout Maryland SILVER SPRING, MD / ACCESS Newswire /...
Phase 3 data for intismeran autogene in the adjuvant treatment of patients with resected stage IIB-IV melanoma selected for presentation...
The paper introduces three interconnected resources for the global scientific community:LongevityBench, the first open benchmark designed to rigorously evaluate AI...
HENDERSON, Nev., Sept. 17, 2026 /PRNewswire/ --Â VolitionRx Limited (NYSE AMERICAN: VNRX) (XASE: VNRX) (together with affiliates "Volition"), a multi-national epigenetics...
Vitality AI, built on Google Cloud and using Gemini Enterprise, expands into the U.S. market — bringing proven personalized health recommendations,...
Opinion: Current lung cancer screening policy leaves gaps around air pollution, exposure, and genetics. Two new trials in India are...
Longevity Biotech Report forecasts a $617bn market by 2045.LONDON, Sept. 16, 2026 /PRNewswire/ -- Global investment in longevity biotech reached...
In this free webinar, learn how sponsors can evaluate when emerging science in oncology is ready for clinical development and...
Initial Real-World User-Submitted Images Now in Internal Review, Advancing the Platform Beyond Public Cancer Imaging Archives MESA, AZ / ACCESS...
Nanomolar potency against PLpro with broad-spectrum SARS-CoV-2 variants activitySignificant dose-dependent suppression of pulmonary viral replication in vivoStrong oral bioavailability and...